Soleo Health tapped to distribute two new drugs

 - 
Thursday, June 28, 2018

MCKINNEY, Texas – Soleo Health has been selected by Genetech to dispense two limited distribution drugs, Hemlibra for patients with hemophilia A with factor VIII inhibitors; and Ocrevus for patients with a relapsing or primary progressive form of multiple sclerosis. Soleo Health has extensive experience treating these patient groups. “Being part of manufacturer limited drug distribution networks expands Soleo Health’s clinical service offering for patients, providers and payers, and helps fuel our continued rapid growth,” said Craig Vollmer, executive vice president and Soleo Health, in a press release. “This is a testament to our reputation and commitment to providing outstanding patient care, as well as our dedication to improving clinical outcomes.”